Gastric cancer (GC) is globally the fifth most common cancer and third leading cause of
cancer death. A complex disease arising from the interaction of environmental and host …

Gastric cancer is one of the leading causes of cancer mortality in the world. Aberrant
expression of microRNAs (miRNAs) is the hallmark of this disease. MiRNAs are …

Emerging evidence suggests that mesenchymal stem cells (MSCs) are often recruited to
tumor sites but their functional significance in tumor growth and disease progression …

Recent technology has made it possible to simultaneously perform multi-platform genomic
profiling (eg DNA methylation (DM) and gene expression (GE)) of biological samples …

Background—Pulmonary hypertension (PH) is driven by diverse pathogenic etiologies.
Owing to their pleiotropic actions, microRNA molecules are potential candidates for …

Gastric carcinogenesis is a multistep process involving genetic and epigenetic alteration of
protein-coding proto-oncogenes and tumor-suppressor genes. Recent discoveries have …

Objective Serum α-fetoprotein (AFP) is the most commonly used biomarker for screening
hepatocellular carcinoma (HCC) but fails to detect about half of the patients. Thus, we …

Carcinoma of the stomach is one of the most prevalent cancer types in the world. Although
the incidence of gastric cancer is declining, the outcomes of gastric cancer patients remain …

Aberrantly expressed microRNA (miRNA) is frequently associated with a variety of cancers,
including pancreatic ductal adenocarcinoma (PDAC). In this study, we investigated the …

The incidence of gastroesophageal cancers is increasing each year, but despite much
research, their molecular mechanisms are incompletely understood. microRNAs (miRNAs) …